Co-GP / Platform:A family office could deploy into this market by partnering with developers like Longfellow Real Estate or King Street Properties to co-GP on new life sciences projects.

Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of development projects.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing established developers like Sterling Bay or IQHQ at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor or operator at the GP level, capitalizing on the increased venture capital funding and the demand for new facilities.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator in a co-GP or JV equity arrangement to capitalize on the growing demand for life sciences facilities.

Co-GP / Platform:A family office could deploy into the Toronto life sciences market by backing a sponsor/operator at the GP level, particularly in projects like the biomanufacturing facilities being developed by McMaster University.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator focused on life sciences developments, sharing in the promote and benefiting from a repeatable pipeline of projects.

Co-GP / Platform:A family office could deploy into the Raleigh life sciences market by backing a sponsor/operator at the GP level, focusing on co-GP or JV equity to capitalize on growth opportunities.

Co-GP / Platform:A family office could deploy into the Puget Sound life sciences market by backing a sponsor or operator at the GP level to share in the promote and enhance alignment.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor/operator at the GP level to share in the promote and leverage their expertise.

Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Bay Area life science market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Boston life sciences market by backing a sponsor/operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Greater Boston life science market by backing a sponsor or operator at the GP level to share in the promote and benefit from a robust pipeline.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from a robust pipeline of opportunities.

Co-GP / Platform:A family office could deploy into Houston's life sciences market by backing a sponsor or operator at the GP level, particularly in developments like TMC Helix Park, to share in the promote and benefit from the area's strong funding environment.

Co-GP / Platform:A family office could deploy into the Puget Sound life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from a repeatable investment pipeline.

Co-GP / Platform:A family office could deploy into the Greater Boston life sciences market by backing a specialized operator at the GP level, facilitating access to a robust pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor that is well-positioned to capitalize on the demand for lab space and R&D funding as drug patents expire.

Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from a strong deal pipeline.

Co-GP / Platform:A family office could deploy into the Houston life sciences market by backing a specialized operator at the GP level, sharing in the promote and benefiting from a repeatable pipeline.

Co-GP / Platform:A family office could deploy into the Raleigh-Durham life sciences market by backing a sponsor/operator at the GP level to share in the promote and access a pipeline of investment opportunities.